Institutional Ownership Zentalis Pharmaceuticals, Inc. (ZNTL)
This table provides information about the institutional ownership of Zentalis Pharmaceuticals, Inc. (ZNTL). We have compiled data on the 107 institutions that hold shares in the stock, with a total of 58 Million shares, which have been reported (via 13F filing form) to have a value of $77.2 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
Nov 04, 2025 Q3 2025 |
28
shares
|
$37
0.0% of portfolio
|
Q3 2025
Added 3.7%
|
|
|
Ifp Advisors, Inc
|
Dec 02, 2025 Q3 2025 |
24
shares
|
$31
0.0% of portfolio
|
Q3 2025
Reduced 31.43%
|
|
|
Fin Trust Capital Advisors, LLC
|
Oct 11, 2024 Q3 2024 |
17
shares
|
$22
0.0% of portfolio
|
Q3 2023
New holding
|
|
|
Caitong International Asset Management Co., LTD
Hong Kong, K3 |
Nov 19, 2025 Q3 2025 |
1
shares
|
$1
0.0% of portfolio
|
Q3 2025
Reduced 99.96%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Aug 12, 2025 Q2 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q2 2025
New holding
|